Human genes in TB infection: Their role in immune response

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 69, Issue 1, 2008, Pages 24-31

  Lykouras, D ^a   Sampsonas, F ^a   Kaparianos, A ^a   Karkoulias, K ^a   Tsoukalas, G ^b   Spiropoulos, K ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b Chest Diseases Hospital Sotiria   (Greece)

Author keywords

Cytokines; Genes; Polymorphism; TB; Vitamin D

Indexed keywords

ARGININE; BACTERIAL ANTIGEN; CARRIER PROTEIN; CYTOKINE; GAMMA INTERFERON; GLUTAMINE; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; MYCOBACTERIUM TUBERCULOSIS ANTIGEN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROTEIN APAI; PROTEIN BSMI; PROTEIN FOKI; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 22; RAB PROTEIN; RAB27A PROTEIN; RAB5 PROTEIN; RAB7 PROTEIN; RAS PROTEIN; RECEPTOR PROTEIN; SOLUTE CARRIER FAMILY 11A MEMBER 1 PROTEIN; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ALLELE; CELLULAR IMMUNITY; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN GENETICS; IMMUNE RESPONSE; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; LATENT PERIOD; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; TH1 CELL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 42549114365     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2008.408     Document Type: Review

References (56)

1. Krutzik SR, Modlin RL. The role of Toll-like receptors in combating mycobacteria. Semin Immunol 2004; 16: 35-41.
2. Padmini Salgame. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Current Opinion in Immunology 2005; 17: 374-380.
3. Hill AV. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genom Hum Genet 2001 2: 373-400.
4. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22: 599-623.
5. Ogata K, Linzer BA, Zuberi RI, et al. A. Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun 1992; 60: 4720-5.
6. Ratcliffe LT, Lukey PT, MacKenzie CR, et al. Reduced NK activity correlates with active disease in HIVpatients with multidrug-resistant pulmonary tuberculosis. Clin Exp Immunol 1994; 97: 373-9.
7. Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991; 84: 200-6.
8. Saltini C. Chemotherapy and diagnosis of tuberculosis. Resp Med 2006; 100: 2085-2097.
9. Meyer CG, May J, Starkx K. Human leukocyte antigens in tuberculosis and leprosy. Trends Microbiol 1998; 6: 148-154.
10. Goldfeld AE, Delgado JC, et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279: 226-228.
11. Dubaniewicz A, Moszkowska G, Szczerkowska, et al. Analysis of DQB1 allele frequencies in pulmonary tuberculosis: preliminary report. Thorax 2003; 58, 890-891.
12. Hill RJ, Zozulya S, Lu YL, et al. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 2002; 30: 237-44.
13. Cloutier JF, Veillette A. Cooperative inhibition of T- cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189: 111.
14. Gomez LM, Anaya J-M, Martin J. Genetic Influence of PTPN22 R620W Polymorphism in Tuberculosis. Human Immunology 2005; 66: 1242-1247.
15. Means TK, Jones BW, Schromm AB, et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001; 166: 4074-4082.
16. Supajatura V, Ushio H, Nakao A, et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109: 1351-1359.
17. Means TK, Wang S, Lien E, Yoshimura A, et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 3920-3927.
18. Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001; 291: 1544-1547.
19. Lorenz E, Mira JP, Cornish KL, et al. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398-6401.
20. Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753G1n polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219-223.
21. Liu PT, Stenger S, Li H, et al. Toll-Like Receptor triggering of a Vitamin D-Mediated Human Antimicrobial response. Science 2006; 311: 1770-1773.
22. Bellamy R. Susceptibility to mycobacterial infections: The importance of host genetics. Genes Immun 2003; 4: 4-11.
23. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxy vitamin D3: A novel immunoregulatory hormone. Science 1984; 224: 1438-1440.
24. Malloy PJ, Feldman D. Vitamin D resistance. Am J Med 1999; 106: 355-370.
25. Arai H, Miyamoto K, Taketani Y, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997; 12: 915-921.
26. Sharma OP. Hypercalcemia in granulomatous disorders. A clinical review. Curr Opin Pul Med 2000; 6: 442-447.
27. Govoni G, Vidal S, Cellier M, et al. Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics 1995; 27: 9.
28. Wicker LS, Chamberlain G, Hunter, et al. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J Immunol 2004; 73: 164-73.
29. Vidal S, Tremblay ML, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995; 182: 655.
30. Bellamy R, Beyers N, McAdam K, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. PNAS 2000; 97: 8005.
31. Awomoyi AA, Marchant, et al. Interleukin-10, polymorphism in SLC1A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002; 186: 1808.
32. El Baghdadi J, Remus N, Benslimane. Variants of the human NRAMP1 gene and susceptibility to tuberculosis in Morocco. Intern J Tubercle Lung Dis 2003; 7: 599.
33. Taype CA, Castro JC, Accinelli RA, et al. Espinoza. Association between SLC11A1 polymorphisms and susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infection, Genetics and Evolution 2006; 6: 361-367.
34. Yip SP, Leung KH, Lin CK. Extent and distribution of linkage disequilibrium around the SLC11Aa locus. Genes and Immunity 2003; 4: 212.
35. Buu NT, Cellier M, Gros P, et al. Identification of a highly polymorphic length variant in the 3'UTR of NRAMP1. Immunogenetics 1995; 42: 428.
36. Lazarevic V, Flynn J. CD8+ T cells in tuberculosis. Am J Respir Crit Care Med 2002; 166: 1116-21.
37. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001; 1: 20-30.
38. Via LE, Deretic D, Ulmer RJ, et al. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J Biol Chem 1997; 272: 13326-31.
39. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001; 2: 107-17.
40. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003; 302: 654-9.
41. Bellamy R, Beyers N, McAdam KP, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 2000; 97: 8005-9.
42. Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282: 121-5.
43. Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium, tuberculosis survival in infected macrophages. Cell 2004; 119: 753-66.
44. Morimoto S, Nishimura N, Terai T, et al. Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem 2004; 280: 2220-8.
45. Sanchez FO, Rodriguez JI, Agudelo G, et al. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994; 62: 5673-8.
46. Altare F, Jouanguy E, Lamhamedi S, et al. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 1998; 10: 413-7.
47. Bean AGD, Roach DR, Briscoe H, et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999; 162: 3504-11.
48. Gil DP, Leon LG, Correa LI, et al. Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy controls. J Infect Dis 2004; 189: 2120-8.
49. Saunders BM, Frank AA, Orme IM, et al. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 2000; 68: 3322-6.
50. Rossouw M, Nel HJ, Cooke GS, et al. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003; 361: 1871-2.
51. Honer zu Bentrup K, Russell DG. Mycobacterial persistence: adaptation to a changing environment. Trends Microbiol 2001; 9: 597-605.
52. Hu Y, Coates AR. Transcription of the stationary-phase-associated hspX gene of Mycobacterium tuberculosis is inversely related to synthesis of the 16-kilo-dalton protein. J Bacteriol 1999; 181: 1380-1387.
53. Voskuil MI, Schnappinger D, Visconti KC, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 2003; 198: 705-713.
54. Yuan Y, Crane DD, Simpson RM, et al. The 16-kDa a-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA 1998; 95: 9578-9583.
55. Ebrahimi Rad M, Bifani P, Martin C, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 2004; 10: 1337-8.
56. Heinke Kunst. Diagnosis of latent tuberculosis infection: The potential role of new technologies. Resp Med 2006; 100, 2098-2106.